anmelden
FTSE 100
10.751,51
PKT
-21,16
PKT
-0,20
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 09.04.25 | HSBC Buy | Jefferies & Company Inc. | |
| 08.04.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 08.04.25 | Diageo Buy | Jefferies & Company Inc. | |
| 08.04.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 08.04.25 | HSBC Buy | Goldman Sachs Group Inc. | |
| 08.04.25 | HSBC Sector Perform | RBC Capital Markets | |
| 07.04.25 | GSK Hold | Deutsche Bank AG | |
| 07.04.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 07.04.25 | London Stock Exchange (LSE) Buy | UBS AG | |
| 07.04.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 07.04.25 | Barclays Overweight | JP Morgan Chase & Co. | |
| 07.04.25 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 07.04.25 | London Stock Exchange (LSE) Buy | Jefferies & Company Inc. | |
| 04.04.25 | BP Sector Perform | RBC Capital Markets | |
| 04.04.25 | GSK Hold | Deutsche Bank AG | |
| 04.04.25 | BP Buy | Jefferies & Company Inc. | |
| 04.04.25 | Glencore Buy | Jefferies & Company Inc. | |
| 04.04.25 | Rio Tinto Buy | Jefferies & Company Inc. | |
| 03.04.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 03.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 03.04.25 | GSK Outperform | Bernstein Research | |
| 03.04.25 | Diageo Buy | UBS AG | |
| 03.04.25 | Glencore Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.04.25 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.04.25 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 02.04.25 | BP Buy | Goldman Sachs Group Inc. | |
| 02.04.25 | Diageo Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.04.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 01.04.25 | International Consolidated Airlines Buy | Deutsche Bank AG | |
| 01.04.25 | AstraZeneca Buy | UBS AG | |
| 01.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.04.25 | BP Neutral | JP Morgan Chase & Co. | |
| 01.04.25 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 31.03.25 | HSBC Neutral | UBS AG | |
| 31.03.25 | Vodafone Group Buy | Deutsche Bank AG | |
| 28.03.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 28.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 28.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.
